Home About us Articles Multimedia Search Instructions Login 
5 years IF: 1.036 (® Thomson Reuters)
IF 2016: 1.064 (® Thomson Reuters)
Total Cites: 7140
Follow Us
Follow Us
  • Users Online: 2014
  • Home
  • Print this page
  • Email this page

    Article Cited by others


HBcrAg Identifies Patients Failing to Achieve HBeAg Seroconversion Treated with Pegylated Interferon Alfa-2b

Ma Hui, Yang Rui-Feng, Li Xiao-He, Jin Qian, Wei Lai

Year : 2016| Volume: 129| Issue : 18 | Page no: 2212-2219

   This article has been cited by
1 Hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection
L.-Y. Mak,D. K.-H. Wong,K.-S. Cheung,W.-K. Seto,C.-L. Lai,M.-F. Yuen
Alimentary Pharmacology & Therapeutics. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Current advances in the elimination of hepatitis B in China by 2030
Shuye Zhang,Fusheng Wang,Zheng Zhang
Frontiers of Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article